Alkermes Investigational Site

Austin, Texas 78759

3 studies enrolling now · 20 studies all time

What they study most

Alcohol Use Disorder, Bipolar I Disorder, Healthy, Idiopathic Hypersomnia, Major Depressive Disorder, Multiple Sclerosis, Narcolepsy Type 1, Narcolepsy Type 2, OIC, Schizophrenia, Schizophreniform Disorder

Studies at this site

• A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 — Recruiting now
• A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 — Recruiting now
• A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia — Recruiting now
• A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201) — Completed
• Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 — Completed
• Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) — Completed
• A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) — Completed
• A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study — Completed
• A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD) — Completed
• A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed
• A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) — Completed
• An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia — Completed
• A Study of [14c]-Samidorphan (Also Known as ALKS 33) in Healthy, Male Volunteers — Completed
• ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC) — Completed